Shunt reduction with a fenestrated Amplatzer device

Catheterization and Cardiovascular Interventions

Volumn 76, Issue 4, 2010, Pages 564-571

  Kretschmar, Oliver ^a   Sglimbea, Anca ^a   Corti, Roberto ^b   Knirsch, Walter ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

atrial septal defect; congenital heart disease; fenestrations; Fontan; interventional device closure; shunt

Indexed keywords

ANTICOAGULANT AGENT; BISOPROLOL; BOSENTAN; BRAIN NATRIURETIC PEPTIDE; DIURETIC AGENT; FUROSEMIDE; LISINOPRIL; MILRINONE; NONABSORBABLE SUTURE; SILDENAFIL; TORASEMIDE;

ADOLESCENT; AGED; ANTICOAGULATION; AORTA COARCTATION; ARTICLE; BALLOON DILATATION; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONGESTIVE HEART FAILURE; CORONARY STENT; CYANOSIS; FEMALE; FENESTRATION; FOLLOW UP; FONTAN PROCEDURE; GUIDE WIRE; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART LEFT RIGHT SHUNT; HEART RIGHT LEFT SHUNT; HUMAN; LUNG ARTERY PRESSURE; MALE; OXYGEN SATURATION; OXYGEN THERAPY; PRESCHOOL CHILD; PROTEIN LOSING GASTROENTEROPATHY; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SEPTAL OCCLUDER; SURGICAL EQUIPMENT; SUTURE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADMINISTRATION, ORAL; ADOLESCENT; AGED; ANTICOAGULANTS; BALLOON DILATION; CHILD, PRESCHOOL; CORONARY CIRCULATION; FEMALE; FONTAN PROCEDURE; HEART CATHETERIZATION; HEART DEFECTS, CONGENITAL; HEART SEPTAL DEFECTS, ATRIAL; HEART SEPTAL DEFECTS, VENTRICULAR; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MALE; PROSTHESIS DESIGN; PULMONARY CIRCULATION; RETROSPECTIVE STUDIES; SEPTAL OCCLUDER DEVICE; SUTURE TECHNIQUES; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 78649425541     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22556     Document Type: Article

References (18)

1. Fischer G, Stieh J, Uebing A, Hoffmann U, Morf G, Kramer HH,. Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: A single centre study in 236 consecutive patients. Heart 2003; 89: 199-204.
2. Micheletti A, Hislop AA, Lammers A, Bonhoeffer P, Derrick G, Rees P, Haworth SG,. Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension. Heart 2006; 92: 969-972.
3. Pihkala J, Yazaki S, Mehta R, Lee K, Chaturvedi R, McCrindle BW, Van Arsdell G, Benson LN,. Feasability and clinical impact of transcatheter closure of interatrail communications after a fenestrated Fontan procedure: Medium-term outcomes. Catheter Cardiovasc Interv 2007; 69: 1007-1014.
4. Marini D, Boudjemline Y, Agnoletti G,. Closure of extracardiac Fontan fenestration by using the covered Cheatham platinum stent. Catheter Cardiovasc Interv 2007; 69: 1003-1006.
5. Chatrath R, Cabalka AK, Driscoll DJ, Hagler DJ,. Fenestrated amplatzer device for percutaneous creation of interatrial communication in patients after Fontan operation. Catheter Cardiovasc Interv 2003; 60: 88-93.
6. Peters B, Ewert P, Schubert S, Abdul-Khaliq H, Schmitt B, Nagdyman N, Berger F,. Self-fabricated fenestrated amplatzer occluders for transcatheter closure of atrial septal defect in patients with left ventricular restriction: Midterm results. Clin Res Cardiol 2006; 95: 88-92.
7. Holzer R, Cao QL, Hijazi ZM,. Closure of a moderately large atrial septal defect with a self-fabricated fenestrated amplatzer septal occluder in an 85-year-old patient with reduced diastolic elasticity of the left ventricle. Catheter Cardiovasc Interv 2005; 64: 513-518.
8. Lammers AE, Derrick G, Haworth SG, Bonhoeffer P, Yates R,. Efficacy and long-term patency of fenestrated amplatzer devices in children. Catheter Cardiovasc Interv 2007; 70: 578-584.
9. Kong H, Gu X, Titus JL, Kim T, Urness M, Han Y, Hessliein P, Bass J, Chun M, Hunter DW,. Creation of an intra-atrial communication with a new Amplatzer shunt prosthesis: Preliminary results in a swine model. Catheter Cardiovasc Interv 2002; 56: 267-271.
10. Amin Z, Danford DA, Pedra CAC,. A new Amplatzer device to maintain patency of Fontan fenestrations and atrial septal defects. Catheter Cardiovasc Interv 2002; 57: 246-251.
11. Boshoff DE, Brown SC, Degiovanni J, Stumper O, Wright J, Mertens L, Gewillig M,. Percutaneous management of a Fontan fenestration: in search for the ideal restriction-occlusion device. Catheter Cardiovasc Interv 2010; 75: 60-65.
12. Ewert P, Berger F, Nagdyman N, Kretschmar O, Dittrich S, Abdul-Khaliq H, Lange PE,. Masked left ventricular restriction in elderly patients with atrial septal defects: A contraindication for closure? Catheter Cardiovasc Interv 2001; 52: 177-180.
13. Schubert S, Peters B, Abdul-Khaliq H, Nagdyman N, Lange PE, Ewert P,. Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defect. Catheter Cardiovasc Interv 2005; 64: 333-337.
14. Tomai F, Gaspardone A, Papa M, Polisca P,. Acute left ventricular failure after transcatheter closure of a secundum atrial septal defect in a patient with coronary artery disease: A critical reappraisal. Catheter Cardiovasc Interv 2002; 55: 97-99.
15. Sommer RJ, Recto M, Golinko RJ, Griepp RB,. Transcatheter coil occlusion of surgical fenestration after Fontan operation. Circulation 1996; 94: 249-252.
16. Tofeig M, Walsh KP, Chan C, Laudsans E, Gladman G, Arnold R,. Occlusion of Fontan fenestrations using the Amplatzer septal occluder. Heart 1998; 79: 368-370.
17. Rueda F, Squitieri C, Ballerini L,. Closure of the fenestration in the extracardiac Fontan with the amplatzer duct occluder device. Catheter Cardiovasc Interv 2001; 54: 88-92.
18. Goff DA, Blume ED, Gauvreau K, Mayer JE, Lock JE, Jenkins KJ,. Clinical outcome of fenestrated Fontan patients after closure: The first 10 years. Circulation 2000; 102: 2094-2099.